Bubpivacaine

PreclinicalSmall molecule

SSuez Canal University

Bubpivacaine is one of 5 small molecule programs targeting Umbilical hernia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Umbilical HerniaActive, not recruiting

Umbilical HerniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Umbilical Hernia

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Approved

1 2

Duragesic

CCephalon

Approved

1 3

Naropin

FFresenius Kabi Oncology Ltd.

Preclinical

1 4

Decadron

AAspen Global Incorporated

Preclinical

1 5

Bubpivacaine

SSuez Canal University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Umbilical hernia1 trial

U.S. Guided Erector Spinae Block for Postoperative Pain Management in Paraumbilical Hernia Repair Patients

Unknown status·—··NCT06120088·300 enrolled

Dexmedetomidine1 trial

Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain

Enrolling by invitation·—·Phase 1·NCT07380139·90 enrolled

Erector Spinae Plane Block1 trial

Erector Spinae Plane Block as Analgesia in Patients for Colectomy

Completed·SSuez Canal University·N/A·NCT06957574·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Bubpivacaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bubpivacaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bubpivacaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Suez Canal University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSuez Canal University

Bubpivacaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Umbilical hernia1 trial

Dexmedetomidine1 trial

Erector Spinae Plane Block1 trial

References

Drug Info

Quick Facts

Related News